Sci-Tech Times Uzbekistan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Times Uzbekistan.

Press releases published on October 19, 2026

an hour ago

SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications

Indeterminate GlobeNewswire

an hour ago

Bel Fuse Schedules Third Quarter 2026 Financial Results Conference Call

Indeterminate GlobeNewswire

an hour ago

NTHU Signs Exclusive Collaboration Agreement with NuCube Energy to Explore Deploying NuSun™ Microreactors for Power, Research, and Medical Applications

Indeterminate GlobeNewswire

an hour ago

Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026

Indeterminate GlobeNewswire

an hour ago

Indivior to Report Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026

Indeterminate GlobeNewswire

an hour ago

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine

Indeterminate GlobeNewswire

an hour ago

Roze AI Signs MOA Targeting Approximately US$111.8 Million in AI Fire Safety and Related Project Work

Indeterminate GlobeNewswire

an hour ago

Roze AI, 약 1,500억 원(US$111.8M) 목표로 AI 화재안전·관련 공사 협력 MOA 체결

Indeterminate GlobeNewswire

an hour ago

Beyond Copper: Fabric.AI and Kopin Model Up to 60% Increase in GPU Utilization in a Neural I/o™-Powered Data Center

Indeterminate GlobeNewswire

an hour ago

The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

Indeterminate GlobeNewswire

an hour ago

Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting

Indeterminate GlobeNewswire

an hour ago

Zone Frontier Inc. Announces 1-for-60 Reverse Stock Split

Indeterminate GlobeNewswire

an hour ago

Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

an hour ago

Data I/O Signs Definitive Agreement to Acquire V-TEK and A&J Programming

Indeterminate GlobeNewswire

an hour ago

MKS Inc. to Sell Its Ophir® Optics Business to TTM Technologies, Inc.

Indeterminate GlobeNewswire

an hour ago

Envoy Drives East Coast Expansion Forward with $8.1 Million Grant-Funded New Jersey Initiative

Indeterminate GlobeNewswire

an hour ago

QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

an hour ago

argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026

Indeterminate GlobeNewswire

an hour ago

Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS

Indeterminate GlobeNewswire